David A. Spellman, SVP, CFO and Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 127,134 shares at $1.07 ($136K) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Open-market sale of $136k AKBA by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.07 | 63,567 | $68K | 50.0% |
| 2 | $1.07 | 63,567 | $68K | 50.0% |
| Total | $1.07 avg | 127,134 | $136K | 100% |
| Filing → |
| AKBA | SELL | 2022-03-02 | $18K | — | Filing → |
| AKBA | SELL | 2021-04-01 | $3K | — | Filing → |